HEPION PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
HEPION PHARMACEUTICALS, INC. (HEPA) had Lessee, Operating Lease, Liability, to be Paid, Year One of $97.81 thousand as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2024-11-14
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $97.81K.
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $97.81K.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $97.81K.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $137.33K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2024-09-30 | $97.81K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $97.81K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $97.81K 10-Q · filed 2024-05-21 |
| 2023-12-31 | $137.33K 10-K · filed 2024-04-16 |
| 2023-09-30 | $137.60K 10-Q · filed 2023-11-20 |
| 2022-12-31 | $53.90K 10-K · filed 2023-04-10 |
| 2022-09-30 | $53.90K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $53.90K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $53.90K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $273.94K 10-K · filed 2022-04-08 |
| 2021-09-30 | $273.94K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $275.67K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $271.88K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $287.98K 10-K · filed 2021-03-31 |
| 2020-09-30 | $285.93K 10-Q · filed 2020-11-16 |
| 2019-12-31 | $274.82K 10-K · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |